8-K filed May 8, 2026, 7:59 PM ET ticker TKR CIK 0000098362

other material confidence high sentiment neutral materiality 0.30

Timken enters retention agreement with EVP Hansal Patel through June 2028

TIMKEN CO

Hansal N. Patel, EVP General Counsel & Corporate Development, receives special vesting on equity and STIP to retain him until June 30, 2028.
Performance and time-based RSUs will vest prorated upon a qualifying termination after the retention date with 90-day notice.
Unpaid STIP awards for prior and current year remain eligible if Patel stays through retention and has a qualifying termination.
Non-compliance with restrictive covenants forfeits the special vesting benefits outlined in the letter agreement.
At 2026 annual meeting, all 12 director nominees elected; say-on-pay and auditor ratified; shareholder special-meeting proposal rejected.

item 5.02 item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0000098362-26-000035
form_type: 8-K
ticker: TKR
cik: 0000098362
company_name: TIMKEN CO
filed_at: 2026-05-08T23:59:59+00:00
discovered_at: 2026-05-14T18:02:33.971002+00:00
generated_at: 2026-05-14T21:19:00.963292+00:00
sec_items: ["5.02", "5.07", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0000098362-26-000035
json_url: https://secwatch.observer/filing/0000098362-26-000035.json
markdown_url: https://secwatch.observer/filing/0000098362-26-000035.md
text_url: https://secwatch.observer/filing/0000098362-26-000035.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/98362/000009836226000035/0000098362-26-000035-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/98362/000009836226000035/tkr-20260508.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

5315c1aa644417d9327626de89d7a344768c9fb8

TIMKEN CO shareholders approved Ratification of Ernst & Young LLP as independent auditor at the 2026-05-08 meeting.

(3) ratified the appointment of Ernst & Young LLP as its independent auditor for the fiscal year ending December 31, 2026; and FOR AGAINST ABSTAIN BROKER NON-VOTES 61,717,389 1,977,231 35,539 0

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

7a62898e874c107075d80bf1720892b64649e218

TIMKEN CO shareholders approved Advisory approval of named executive officer compensation at the 2026-05-08 meeting.

(2) approved, on an advisory basis, the resolution set forth below regarding named executive officer compensation; RESOLVED, that the compensation of the named executive officers as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, the compensation tables and any related material disclosed in the 2026 Proxy Statement, is hereby APPROVED. FOR AGAINST ABSTAIN BROKER NON-VOTES 44,837,026 15,272,988 437,466 3,182,679

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

8193f028cbff174e4270339f6a45c19ada79c8b8

TIMKEN CO shareholders rejected Shareholder proposal to amend governing documents to allow 10% shareholders to call special meeting at the 2026-05-08 meeting.

(4) did not approve a shareholder proposal requesting that the Board of Directors take the steps necessary to amend the appropriate Company governing documents to give the owners of a combined 10% of our outstanding common stock the power to call a special shareholder meeting or the owners of the lowest percentage of shareholders, as governed by state law, the power to call a special shareholder meeting. FOR AGAINST ABSTAIN BROKER NON-VOTES 24,930,334 35,358,915 258,231 3,182,679

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

c64dfb7fdcbc4499d29909a79c3b899889f8e8b8

TIMKEN CO shareholders approved Election of twelve directors at the 2026-05-08 meeting.

(1) elected the twelve Directors set forth below to serve for a term of one year expiring at the annual meeting in 2027 (or until their respective successors are elected and qualified); NOMINEES FOR WITHHOLD BROKER NON-VOTES Lucian Boldea 59,598,638 948,854 3,182,667 Maria A. Crowe 58,028,580 2,518,912 3,182,667 Elizabeth A. Harrell 58,197,705 2,349,787 3,182,667 Richard G. Kyle 59,605,368 942,124 3,182,667 Sarah C. Lauber 59,271,708 1,275,784 3,182,667 Todd M. Leombruno 58,659,558 1,887,934 3,182,667 Christopher L. Mapes 55,431,064 5,116,428 3,182,667 Ajita G. Rajendra 53,788,853 6,758,639 3,182,667 Kimberly K. Ryan 59,475,084 1,072,408 3,182,667 Frank C. Sullivan 57,747,501 2,799,991 3,182,667 John M. Timken, Jr. 58,945,757 1,601,735 3,182,667 Ward J. Timken, Jr. 59,599,013 948,479 3,182,667

SEC 8-K Item 5.07 confidence 0.95 SEC evidence

Comparable filings

BRANDYWINE OPERATING PARTNERSHIP, L.P.

Brandywine extends revolver maturity to Dec 2026; shareholders OK 5M share increase for LTIP

BRANDYWINE OPERATING PARTNERSHIP, L.P. June 1, 2026, 4:30 PM ET other_material Items 1.01, 2.03, 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

This filing

(3) ratified the appointment of Ernst & Young LLP as its independent auditor for the fiscal year ending December 31, 2026; and FOR AGAINST ABSTAIN BROKER NON-VOTES 61,717,389 1,977,231 35,539 0

Comparable filing

PROPOSAL 2. Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for calendar year 2026. Votes For Votes Against Abstentions 134,853,955 7,100,190 646,621

Filing page SEC filing

CYTK

Cytokinetics director Smith resigns; stockholders approve 300K-share ESPP increase

CYTOKINETICS INC May 17, 2024, 7:59 PM ET other_material Items 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

This filing

(3) ratified the appointment of Ernst & Young LLP as its independent auditor for the fiscal year ending December 31, 2026; and FOR AGAINST ABSTAIN BROKER NON-VOTES 61,717,389 1,977,231 35,539 0

Comparable filing

Proposal 2: Approval of the Amendment and Restatement of the Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of shares authorized for issuance under such plan by 300,000 shares of common stock. The stockholders approved the Amendment and Restatement of the Company's Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of shares authorized for issuance under such plan by 300,000 shares of common stock. The votes were as follows: For Against Abstain Broker Non-Vote 88,586,473 481,098 464,524 6,649,555

Filing page SEC filing

MPT

MPT shareholders elect all directors, approve say-on-pay and equity plan with notable opposition

MEDICAL PROPERTIES TRUST INC June 1, 2026, 4:55 PM ET other_material Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other_material similar materiality

This filing

(3) ratified the appointment of Ernst & Young LLP as its independent auditor for the fiscal year ending December 31, 2026; and FOR AGAINST ABSTAIN BROKER NON-VOTES 61,717,389 1,977,231 35,539 0

Comparable filing

Proposal 2: The ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026: For: Against: Abstensions: Broker Non-Votes: 459,883,831 6,189,396 2,613,330 —

Filing page SEC filing

LODE

Comstock holds AGM; all director nominees elected, auditor and equity plan approved

Comstock Inc. June 1, 2026, 4:15 PM ET other_material Items 5.07, 7.01, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other_material similar materiality

This filing

(3) ratified the appointment of Ernst & Young LLP as its independent auditor for the fiscal year ending December 31, 2026; and FOR AGAINST ABSTAIN BROKER NON-VOTES 61,717,389 1,977,231 35,539 0

Comparable filing

4. Vote on Comstock Inc. 2026 Equity Incentive Plan. The stockholders approved the Comstock Inc. 2026 Equity Incentive Plan as set forth below. Voted For Voted Against Abstain Broker Non-Votes 25,069,375 1,393,479 1,194,028 21,410,649

Filing page SEC filing

HNVR

Shareholders elect three directors, approve equity plan, ratify auditor at annual meeting

Hanover Bancorp, Inc. /MD June 1, 2026, 4:00 PM ET other_material Items 5.02, 5.07

same fact type: shareholder_vote same SEC item: 5.02, 5.07 same event type: other_material similar materiality

This filing

(3) ratified the appointment of Ernst & Young LLP as its independent auditor for the fiscal year ending December 31, 2026; and FOR AGAINST ABSTAIN BROKER NON-VOTES 61,717,389 1,977,231 35,539 0

Comparable filing

2. The Hanover Bancorp, Inc. 2026 Equity Incentive Plan was approved by the shareholders by the following vote: FOR AGAINST ABSTAIN 4,755,228 27,522 43,684 There were 903,723 broker non-votes on the proposal.

Filing page SEC filing

LINC

Annual meeting votes pass; strategic plan presentation attached but content not disclosed

LINCOLN EDUCATIONAL SERVICES CORP May 11, 2026, 7:59 PM ET other_material Items 5.07, 7.01, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other_material similar materiality

This filing

(3) ratified the appointment of Ernst & Young LLP as its independent auditor for the fiscal year ending December 31, 2026; and FOR AGAINST ABSTAIN BROKER NON-VOTES 61,717,389 1,977,231 35,539 0

Comparable filing

Proposal Number 1 : To elect the following 10 individuals named in the Company’s proxy statement as directors of the Company for a one-year term which will expire at the 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified. Each nominee for director was elected by a vote of the shareholders as follows: Nominee Votes For Votes Withheld Broker Non-Votes John A Bartholdson 23,626,016 239,935 3,137,471 James J. Burke, Jr. 23,575,182 290,769 3,137,471 Anna Escobedo Cabral 23,599,841 266,110 3,137,471 Kevin M. Carney 23,628,321 237,630 3,137,471 Marta Newhart 23,615,050 250,901 3,137,471 Michael A Plater 23,479,505 386,446 3,137,471 Felecia J. Pryor 23,612,578 253,373 3,137,471 Carlton E. Rose 23,629,625 236,326 3,137,471 Scott M. Shaw 23,647,094 218,857 3,137,471 Sylvia J. Young 23,631,057 234,894 3,137,471

Filing page SEC filing

MRNA

Moderna amends bylaws for federal forum exclusivity; stockholders re-elect directors

Moderna, Inc. May 11, 2026, 7:59 PM ET other_material Items 5.03, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other_material similar materiality

This filing

(3) ratified the appointment of Ernst & Young LLP as its independent auditor for the fiscal year ending December 31, 2026; and FOR AGAINST ABSTAIN BROKER NON-VOTES 61,717,389 1,977,231 35,539 0

Comparable filing

The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026, with the votes cast as follows:

Filing page SEC filing

PCT

PureCycle shareholders elect all nine directors, ratify auditor, approve say-on-pay at 2026 annual meeting

PureCycle Technologies, Inc. May 11, 2026, 7:59 PM ET other_material Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other_material similar materiality

This filing

(3) ratified the appointment of Ernst & Young LLP as its independent auditor for the fiscal year ending December 31, 2026; and FOR AGAINST ABSTAIN BROKER NON-VOTES 61,717,389 1,977,231 35,539 0

Comparable filing

Proposal 2 – Ratify the appointment of Grant Thornton, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes For Votes Against Abstain Broker Non Vote 127,904,943 406,709 196,157 0

Filing page SEC filing

Source: SEC EDGAR

accession 0000098362-26-000035

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.